Home > Boards > US Listed > Medical - Equipment >

Akers Biosciences Inc. (AKER)

AKER RSS Feed
Add AKER Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 12/2/2020 10:56:55 AM - Followers: 98 - Board type: Free - Posts Today: 0





http://www.akersbio.com/about/company-overview

Akers Biosciences mission is dedicated to solving global health challenges. Akers was founded in 1989 and has over
30 years of success in the health diagnostic industry having developed proprietary, in vitro diagnostic technologies.

In March of 2020, in an attempt to further their mission, Akers announced a strategic partnership with Premas Biotech.
The partnerships primary objective is to focus on novel vaccine candidates.
The emergence of this pandemic offers an opportunity for the company to be a solution in the healthcare space,
one that sets the stage for our next chapter of growth.

http://www.akersbio.com/vaccine/conference-call

Conference Call – Licensing

Akers Biosciences Schedules Conference Call to Discuss Licensing Announcement with Premas Biotech for a Coronvirus Vaccine Candidate

Listen to the replay of the call

Transcript

http://www.akersbio.com/vaccine/covid-19-vaccine-candidate

Covid-19 Vaccine Candidate

Premas develops novel & transformational technologies and partners with global biopharmaceutical companies to build and develop novel biotherapeutic & vaccine candidates.
Akers licensed a novel coronavirus vaccine candidate under development by Premas using Premas’ genetically engineered S. cerevisiae platform, D-Crypt™.

The Premas platform has three key advantages which will set this vaccine candidate apart from industry peers.

  • Premas has previously expressed more than 30 proteins of similar profile to those in the structure of Covid-19,
    therefore the platform is well suited for the expression of difficult vaccine candidate proteins.
    The technology platform is highly scalable with a robust process, which should represent significant cost savings compared to other similar vaccine platforms.
    The current global pandemic might allow for an expedited FDA review timeline based on recent pronouncements regarding other Covid-19 vaccine and treatment candidates.

Premas successfully cloned three Coronavirus antigens, Spike (S), Envelope (E), and Membrane (M) in the first quarter of 2020 which further differentiates our vaccine candidate.
We aim to provide the immune system with several opportunities to identify the virus; a design concept extremely important for efficacy and our future success.

We held a conference call with Prabuddha Kundu, Co-Founder and Managing Director at Premas Biotech, in late March.
The transcript, which provides additional information on our philosophy and milestone timeline, can be accessed here.

 

Notice of Settlement – to current Akers Stockholders

 

 

Particle Immuno-Filtration Assay (PIFA®) Technology

PIFA® technology is a cutting-edge, patented immunoassay method which rapidly, easily, and accurately detects target antigens or antibodies.

How It Works

PIFA® technology is based on the selective filtration of microparticles in response to antibody/antigen binding.
Dyed microparticles coated with antigens or antibodies determine the visual signal for the results of the assay.
The presence of a corresponding antibody or antigen in the test sample results in the formation of a matrix of microparticles, which are more susceptible to filtration.
The inability of these matrixed microparticles to move through the filter, and the resulting color change in the reagent mixture,
signal positive reactivity of the test sample (e.g. the presence of target antigens or antibodies).

Key features of PIFA® technology make it advantageous for a broad array of uses:

  • Accuracy rivaling or surpassing current laboratory methods
    Rapid Results, typically within 1 to 5 minutes
    Point-of-care compatibility
    Easy to use
    Easy to dispose

PIFA® technology is currently used in:

Licensing Availability

PIFA® technology is available for licensing. To inquire about licensing or for technical inquiries, please contact us.

Patent Information

 





https://finviz.com/quote.ashx?t=aker&ty=c&ta=1&p=d
 
Shs Outstand 8.72M
Shs Float 8.30M
Short Float 2.14%
Insider Own 0.83%
Insider Trans -0.83%
Inst Own 4.30%
Book/sh 2.96
Cash/sh 2.00
Debt/Eq     NO DEBT 0.00
52W Range 1.55 - 12.72


[-chart]finviz.com/chart.ashx?t=AKER&ty=c&ta=1&p=d&s=l[/chart]



https://finviz.com/chart.ashx?t=AKER&ty=c&ta=1&p=d&s=l






$AKER  https://www.otcmarkets.com/stock/AKER/disclosure

https://www.otcmarkets.com/stock/AKER/news

https://www.otcmarkets.com/stock/AKER/security

https://www.otcmarkets.com/stock/AKER/profile

https://www.otcmarkets.com/stock/AKER/quote

https://www.otcmarkets.com/stock/AKER/overview







*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.






 
AKER
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AKER News: Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent 12/02/2020 09:00:00 AM
AKER News: Small Company Offering and Sale of Securities Without Registration (d) 11/24/2020 04:40:35 PM
AKER News: Current Report Filing (8-k) 11/20/2020 05:00:42 PM
AKER News: Statement of Ownership (sc 13g) 11/20/2020 04:07:22 PM
AKER News: Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) 11/19/2020 08:49:09 AM
PostSubject
#2107   Anyone ever interested in Anatabloc, anatabine-citrate, etc. might leifsmith 12/02/20 10:56:55 AM
#2106   Today's BIG NEWS on MYMD knuts4oe 12/02/20 10:08:57 AM
#2105   penniespincher MYMD Pharmaceuticals is currently a wholly owned subsidiary knuts4oe 12/01/20 09:21:09 PM
#2104   Thanks - great research! leifsmith 11/30/20 11:52:46 AM
#2103   I agree with your speculation however would that penniespincher 11/28/20 01:25:05 PM
#2102   Think I have finally got my head around knuts4oe 11/26/20 07:54:11 PM
#2101   I read somewhere that the surviving company will leifsmith 11/25/20 02:52:31 PM
#2100   Having much difficulty grasping what this merger is knuts4oe 11/24/20 11:48:49 AM
#2099   Informative article on the MyMD / Akers merger: leifsmith 11/17/20 01:27:31 PM
#2098   MyMd is a venture of Jonnie Williams, who leifsmith 11/16/20 04:40:55 PM
#2097   Just In: $AKER SHAREHOLDER NOTICE: Brodsky & Smith, whytestocks 11/12/20 07:15:18 PM
#2096   * * $AKER Video Chart 11-12-2020 * * ClayTrader 11/12/20 05:51:07 PM
#2095   JUST IN: $AKER ALERT: Rowley Law PLLC is whytestocks 11/12/20 03:45:25 PM
#2094   Breaking News: $AKER What Are Good Penny Stocks whytestocks 11/12/20 11:45:43 AM
#2093   $AKER https://www.nytimes.com/2020/11/09/health/covid-vaccine-pfizer.html SpotOnTrade 11/12/20 11:27:24 AM
#2092   JUST IN: $AKER Akers Biosciences and MyMD Pharmaceuticals whytestocks 11/12/20 10:45:24 AM
#2091   https://ih.advfn.com/stock-market/NASDAQ/akers-biosciences-AKER/stock-news/83669 [SMART MONEY] 11/12/20 09:09:25 AM
#2090   Akers Biosciences In (AKER) mick 10/25/20 03:58:09 PM
#2089   Akers Biosciences In (AKER) mick 09/23/20 09:23:39 PM
#2088   THANK YOU $AKER mick 09/23/20 09:23:30 PM
#2087   agree O/S 8.7mil peterus 09/23/20 03:28:34 PM
#2086   This gets any positive news and it will CELTICAPPLE 09/22/20 09:45:45 PM
#2085   * * $AKER Video Chart 09-08-2020 * * ClayTrader 09/08/20 04:29:43 PM
#2084   Akers Biosciences In (AKER) mick 09/05/20 03:36:40 PM
#2083   $AKER Thorofare, New Jersey, Aug. 27, 2020 (GLOBE mick 09/02/20 04:55:43 PM
#2082   $AKER Amended Current Report Filing (8-k/a) Edgar (US mick 09/02/20 04:31:23 PM
#2081   $AKER Initial Statement of Beneficial Ownership (3) mick 09/02/20 04:31:04 PM
#2080   $AKER Notice of Effectiveness (effect) Edgar (US Regulatory) mick 09/02/20 04:30:38 PM
#2079   $AKER Prospectus Filed Pursuant to Rule 424(b)(5) mick 09/02/20 04:30:01 PM
#2078   Akers Biosciences In (AKER) mick 09/02/20 04:29:10 PM
#2077   Watch for Big Grant Money from Indian Govt shurtha2000 08/27/20 11:25:31 AM
#2076   AKER bouncing after supposedly good scam results? $treet $inatra 08/27/20 10:21:40 AM
#2075   * * $AKER Video Chart 07-20-2020 * * ClayTrader 07/20/20 05:48:25 PM
#2074   Aker having a nice move off bottom today WealthyKing 06/23/20 09:46:18 AM
#2073   * * $AKER Video Chart 05-14-2020 * * ClayTrader 05/14/20 04:34:38 PM
#2072   Is this good news? Paiidnfull38 05/14/20 02:14:15 PM
#2071   Added here Liquid1974 05/14/20 11:09:39 AM
#2070   Check dcar it will double within a week akamaii 05/14/20 10:21:53 AM
#2069   * * * Stock Analyzer AKER 4/24/2020 swingingRichard 04/24/20 09:13:14 AM
#2068   $AKER mjbaker84 04/22/20 08:30:15 AM
#2067   $AKER "We are providing the immune system with SpotOnTrade 04/14/20 01:07:37 PM
#2066   3.7 OS after last weeks offering, at $5 HokieHead 04/11/20 12:12:46 PM
#2065   Akers Biosciences: Here's Why The Licensing Deal With HokieHead 04/09/20 07:32:17 AM
#2064   Akers Biosciences and Premas Biotech Announce Successful Expression HokieHead 04/08/20 09:30:19 AM
#2062   Great Article!- AKER got top mention as a Chess Master 04/08/20 02:16:44 AM
#2061   A vaccine is in high demand, (see the HokieHead 04/07/20 09:39:38 PM
#2060   Let’s hit 10.00 tomorrow! CWO 04/07/20 08:58:50 PM
#2059   +$$$ AKER davidsson10 04/07/20 06:37:45 PM
#2058   By the time it is finalized, and other jeffshir 04/07/20 06:13:10 PM
#2057   * * $AKER Video Chart 04-07-2020 * * ClayTrader 04/07/20 04:37:35 PM
PostSubject
Consent Preferences